Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4 Garima19 May 2019 9:30 AM ISTJubilant Life Sciences said its bottom line in the quarter was hit by a one-time loan settlement with IFC, that resulted in an exceptional item of Rs...
Hikma Pharma backs annual outlook boosted by medicine demand Medical Dialogues Bureau19 May 2019 9:20 AM ISTHikma Pharma expects annual revenue from its injectables division to be between $850 million and $900 million and it's generics unit to be between...
Met Museum: No more money from family connected to OxyContin Medical Dialogues Bureau19 May 2019 9:00 AM ISTNEW YORK: The Metropolitan Museum of Art on Wednesday said it would stop taking monetary gifts from members of the Sackler family who are connected to...
Democrats push bill on health care, drug prices through House Medical Dialogues Bureau19 May 2019 9:00 AM ISTThe measure forced Republicans into the uncomfortable political position of casting a single vote on legislation that contained popular drug pricing...
Aurobindo Pharma: USFDA designates 3 facilities as 'Official Action Indicated' Farhat Nasim18 May 2019 10:00 AM ISTAurobindo Pharma is confident these OAI classifications would not have an impact on the disruption of supplies or revenue from operations of these...
Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 9:45 AM ISTThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study Garima18 May 2019 9:30 AM ISTAbrocitinib, which belongs to a class of drugs known as JAK inhibitors, which block inflammation-causing enzymes, known as Janus kinases, achieved...
Valsartan suppliers faulted over data, bugs, dirt: Report Medical Dialogues Bureau18 May 2019 9:15 AM ISTCadila Healthcare Ltd. and Alkem Laboratories Ltd. both won approvals in March from the Food and Drug Administration to make generic versions of...
Bayer says wont tolerate unethical behaviour as France probes Monsanto file Medical Dialogues Bureau18 May 2019 9:00 AM ISTBayer, which acquired Monsanto in a $63 billion deal last year, faces mounting litigations over its weedkiller Roundup, a systemic, broad-spectrum...
Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names Farhat Nasim17 May 2019 5:37 PM ISTNew Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer Farhat Nasim17 May 2019 1:45 PM ISTIrinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added. NEW DELHI: Shilpa...
Lupin reviews details of US lawsuit on drug price manipulation Farhat Nasim17 May 2019 9:30 AM IST"We have received a copy of the lawsuit filed against the generic drug manufacturers and are reviewing details of the same," Lupin Ltd said in a...
